GFAP and Alzheimer disease: To investigate changes in glial cells in the brains of 3xTg-AD mice, sections of wildtype and 3xTg-AD mice at all timepoints were immuno-stained using antibodies against the microglial marker IBA1 (Figure 7A), or astrocytic markers GFAP and S100β (Figure 7G).